NDC 72854-083 Mucinex Childrens Mighty Chews Cough Daytime And Nighttime Combo Pack

Dextromethorphan Hbr And Doxylamine Succinate Kit - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

Get all the details for National Drug Code (NDC) 72854-083 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
72854-083
Proprietary Name:
Mucinex Childrens Mighty Chews Cough Daytime And Nighttime Combo Pack
Non-Proprietary Name: [1]
Dextromethorphan Hbr And Doxylamine Succinate
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Kit - A packaged collection of related material.
Labeler Name: [5]
Labeler Code:
72854
FDA Application Number: [6]
M012
Marketing Category: [8]
OTC MONOGRAPH DRUG -
Start Marketing Date: [9]
06-03-2024
Listing Expiration Date: [11]
12-31-2025
Exclude Flag: [12]
N
Code Navigator:

Product Characteristics

Color(s):
RED (C48326)
PURPLE (C48327)
Shape:
ROUND (C48348)
Size(s):
234 MM
23 MM
Imprint(s):
M
Score:
1
Flavor(s):
BERRY (C73365 - MIXED BERRY)

Code Structure Chart

Product Details

What is NDC 72854-083?

The NDC code 72854-083 is assigned by the FDA to the product Mucinex Childrens Mighty Chews Cough Daytime And Nighttime Combo Pack which is a human over the counter drug product labeled by Rb Health (us) Llc. The generic name of Mucinex Childrens Mighty Chews Cough Daytime And Nighttime Combo Pack is dextromethorphan hbr and doxylamine succinate. The product's dosage form is kit. The product is distributed in a single package with assigned NDC code 72854-083-32 1 kit in 1 carton * 16 tablet, chewable in 1 bottle (72854-081-16) * 16 tablet, chewable in 1 bottle (72854-082-16). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Mucinex Childrens Mighty Chews Cough Daytime And Nighttime Combo Pack?

Mucinex Children's Mighty Chews Cough Daytime+Mucinex Children's Mighty Chews Cough Nighttime::■ take every 4 hours or as directed by a doctor ■ chew thoroughly before swallowing adults and children 12 years of age and over 2 chewable tablets every 4 hours, not to exceed 12 chewable tablets in any 24-hour period children 6 to under 12 years of age 1 chewable tablet every 4 hours, not to exceed 6 chewable tablets in any 24-hour period children under 6 years of agedo not use

Which are Mucinex Childrens Mighty Chews Cough Daytime And Nighttime Combo Pack UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Mucinex Childrens Mighty Chews Cough Daytime And Nighttime Combo Pack Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Mucinex Childrens Mighty Chews Cough Daytime And Nighttime Combo Pack?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 2683423 - dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG Chewable Tablet
  • RxCUI: 2683423 - dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG Chewable Tablet
  • RxCUI: 2683424 - dextromethorphan hydrobromide 10 MG Chewable Tablet
  • RxCUI: 2683424 - dextromethorphan HBr 10 MG Chewable Tablet
  • RxCUI: 2683425 - {1 (dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG Chewable Tablet) / 1 (dextromethorphan hydrobromide 10 MG Chewable Tablet) } Pack

* Please review the disclaimer below.

Patient Education

Dextromethorphan


Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
[Learn More]


Doxylamine


Doxylamine is used in the short-term treatment of insomnia (difficulty falling asleep or staying asleep). Doxylamine is also used in combination with decongestants and other medications to relieve sneezing, runny nose, and nasal congestion caused by the common cold. Doxylamine should not be used to cause sleepiness in children. Doxylamine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
[Learn More]


* Please review the disclaimer below.

Product Footnotes

[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".